Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione

Pavia 12 trials 2 recruiting

12 Registered trials

2 Currently recruiting

Organisation

Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione

Location

Pavia, Italy

Identifier

ORG-100008202

Address

Via Salvatore Maugeri 4, 27100, Italy

Departments

Medical oncology
N/A
O.U. Nephrology and Hemodialysis
Oncologia
Oncology Unit
U.O. di Oncologia Medica
Unità di Nefrologia e Dialisi
Unità di Nefrologia, Dialisi e Trapianto
UOC di Nefrologia e Dialisi

Clinical trials at this site (12)

Search interface

PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Pending

2025-523425-17-00 Proteinuric kidney diseases 4
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Focal segmental glomerulosclerosis 5 2026-04-02
Neoadjuvant pembrolizumab in high-risk thyroid cancers (NEPENTHE) Recruiting

2024-519129-38-00 thyroid cancers 4 2023-10-25
REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended

2023-506924-94-00 Cardiovascular disease 5 2023-02-28
Efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis Ended

2023-504597-37-00 Focal segmental glomerulosclerosis 5 2022-03-25
Effectiveness and Safety of Sparsentan as treatment for Immunoglobulin A Nephropathy (IgAN) Ended

2023-505495-30-00 Immunoglobulin A Nephropathy (IgAN) 5 2019-02-01
A trial to learn how well durvalumab and chemotherapy with or without tremelimumab work in adults with advanced cancer of the bladder or uri… Ended

2024-510976-19-00 Patients with Unresectable Locally Advanced or Metastat 5 2018-11-30
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A study to learn about how well a new drug called BAY3283142 works and how safe it is in reducing albumin in the urine of people with chroni… Ended

2023-505755-40-00 Chronic kidney disease 4 2024-08-16
A Window-of-Opportunity study of hormone therapy in premenopausal women with ER-positive/HER2-negative early breast cancer. Ended

2022-503013-32-00 ER-positive/HER2-negative early breast cancer 4 2024-01-29
VISIONARY Trial: Phase 3 Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) Ended

2022-500079-30-00 IgA Nephropathy 5 2022-11-03
A trial to learn how well finerenone works and how safe it is in adult participants with non-diabetic chronic kidney disease Ended

2023-506897-11-00 Non-diabetic chronic kidney disease 5 2021-10-18